BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, August 2, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for Dec. 28, 2023

Dec. 28, 2023
New hires and promotions in the med-tech industry, including: Inspire Medical.
Read More

Appointments and advancements for Dec. 27, 2023

Dec. 27, 2023
New hires and promotions in the biopharma industry, including: Harpoon, Nrx.
Read More

Appointments and advancements for Dec. 27, 2023

Dec. 27, 2023
New hires and promotions in the med-tech industry, including: Axogen, Bivacor.
Read More

Appointments and advancements for Dec. 22, 2023

Dec. 22, 2023
New hires and promotions in the med-tech industry, including: Etao International, Olympus Corp., Spectral AI.
Read More

Appointments and advancements for Dec. 21, 2023

Dec. 21, 2023
New hires and promotions in the biopharma industry, including: Acelyrin, Alterity, Disc Medicine, Edenbridge, Eterna, Hervolution, Lift, Myriad Genetics, Pacira.
Read More

Appointments and advancements for Dec. 21, 2023

Dec. 21, 2023
New hires and promotions in the med-tech industry, including: Cardio Diagnostics, United We Care.
Read More

Appointments and advancements for Dec. 20, 2023

Dec. 20, 2023
New hires and promotions in the biopharma industry, including: 858, Cenna, Coya, Cytovation, Deka, Engene, Inhibitor, Lianbio, Scribe.
Read More

Appointments and advancements for Dec. 20, 2023

Dec. 20, 2023
New hires and promotions in the med-tech industry, including: Bioventus, Elligo Health, Quest Diagnostics, Spectrum Solutions, Zerigo Health.
Read More

Appointments and advancements for Dec. 19, 2023

Dec. 19, 2023
New hires and promotions in the biopharma industry, including: 1910 Genetics, AAX, Akiram, Avacta, Endeavor, Impact.
Read More

Appointments and advancements for Dec. 19, 2023

Dec. 19, 2023
New hires and promotions in the med-tech industry, including: Avacta, Biostem Technologies, Impact Biotech, Trinity Biotech.
Read More
Previous 1 2 … 114 115 116 117 118 119 120 121 122 … 329 330 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 31, 2026.
  • HIV virus

    AIDS 2026: New targets for metabolic dysfunction despite ART

    BioWorld
    Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
  • Jingxin discloses new muscarinic and sigma receptor agonists

    BioWorld Science
    Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing